Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Speed of Service We dispatch good on the same or next day as we understand speed of service is just as important as quality
It runs roughly as follows
By mimicking the natural fat-burning properties of growth hormone, AOD9604 enables a focused approach to weight management, making it a subject of significant interest in metabolic research
Heres what the clinical evidence shows: Study Scope: 900+ participants across 6 randomized, double-blind, placebo-controlled trials Safety Profile: Indistinguishable from placebo in tolerability assessments Serious Events: Zero serious adverse events attributed to AOD-9604 Withdrawals: No treatment-related discontinuations in any trial Common Effects: Mild headache and minor GI symptoms at rates similar to placebo IGF-1 Impact: No effect on insulin-like growth factor-1 levels Metabolic Safety: No negative impact on glucose metabolism or insulin sensitivity Immunogenicity: Zero participants developed anti-AOD9604 antibodies The following analysis provides complete details on the clinical trial evidence supporting AOD-9604s favorable safety profile
Kidney Use with Caution ME 12 FORTE INJECTION should be received with caution in patients with kidney problems
